CellSource Co., Ltd.
Status: Publicly traded
Direct answer
CellSource Co., Ltd. is publicly traded on JPX under the ticker 4880.T.
CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Can you invest in CellSource Co., Ltd.?
Yes. CellSource Co., Ltd. trades publicly on JPX as 4880.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CellSource Co., Ltd.
Detailed equity research is provided by MarketSnap.